Pain Therapeutics Summit 2026

September 28-29, 2026
Burlingame, California

The Pain Therapeutics Summit, taking place September 28-29, 2026, in Burlingame, CA, brings together biopharma, academic, and clinical leaders to explore the latest advances in pain research and drug development. The program spans clinical trial design, emerging non-opioid therapies, novel drug targets, and biomarker development, reflecting continued innovation across the pain therapeutics landscape.

For biotech and pharma companies developing novel pain therapeutics, the meeting addresses many of the challenges that directly affect clinical development strategy and study execution, including trial methodology, patient stratification, endpoint selection, and regulatory considerations in a complex and highly variable indication.

Pain trials present unique execution risks, including placebo response, patient heterogeneity, and the need for consistent endpoint collection across sites.

PRC Clinical supports pain programs with targeted clinical strategies and hands-on execution across acute, chronic, neuropathic, and musculoskeletal indications. This includes experience in surgical pain models, complex endpoint management (e.g., NRS, BPI, PGIC), and both opioid and non-opioid development programs, where study design and operational discipline are critical to trial success.

For up-to-date conference information, please visit the conference website linked below. To connect with the PRC Clinical team, fill out the form below.

View the Conference Website